Persistent FDG uptake in large vessels and risk of relapse in giant cell arteritis.

Eur J Intern Med

Service de Médecine Interne, Hôpital Bichat, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université Paris Cité, Centre de Recherche sur l'Inflammation, INSERM UMR1149, CNRS ERL8252, Faculté de Médecine site Bichat, Laboratoire d'Excellence Inflamex, Paris, France. Electronic address:

Published: December 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejim.2022.08.033DOI Listing

Publication Analysis

Top Keywords

persistent fdg
4
fdg uptake
4
uptake large
4
large vessels
4
vessels risk
4
risk relapse
4
relapse giant
4
giant cell
4
cell arteritis
4
persistent
1

Similar Publications

Immune checkpoint inhibitors (ICIs) frequently cause immune-related adverse events (irAEs), with thyroid irAEs being the most common endocrine-related irAEs. The incidence of overt thyroid irAEs ranged 8.9-22.

View Article and Find Full Text PDF

Background: The Coronavirus disease 2019 (COVID‐19), caused by SARS‐CoV‐2, is one of the biggest health concerns of the century. Long COVID is one of the major sequelae from the infection and include persistent neurological manifestations. Brain images study suggest that Long COVID patients present distinct brain metabolic alterations.

View Article and Find Full Text PDF

Background: The COVID‐19 pandemic is a public health crisis, and its lasting consequences are not yet fully understood. Epidemiological data suggest that low‐ and middle‐income countries, such as Brazil, will bear a considerable burden of COVID‐19‐related comorbidities. Individuals who have survived COVID‐19 often report persistent symptoms, including neurological manifestations such as brain fog.

View Article and Find Full Text PDF

Background: Current evidence indicates that COVID‐19 infection can lead to neurological complications that persist beyond 12 weeks of infection (long‐COVID), often associated with cognitive decline. However, the underlying mechanisms remain unclear. Our aim is to study the brain metabolism of patients with long‐COVID and its association with cognitive performance.

View Article and Find Full Text PDF

Background: Cardiovascular disease and dementia often co‐exist at advanced stages. Yet, midlife longitudinal studies examining the interplay between atherosclerosis and its risk factors on brain health are scarce. We aimed to determine the longitudinal associations between cerebral glucose metabolism, subclinical atherosclerosis and cardiovascular risk factors in middle‐aged asymptomatic individuals.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!